Bringing Hope to the Hopeless

Creating therapies and treatments for rare diseases

Learn More

We are the bridge between basic research and clinical trials. It takes many hands to build a bridge.
Make a difference today.

CWHM, a unique approach to solving the puzzle of rare and neglected diseases

News & Updates

  • Story Frans Sverdrup

    One Scientist’s Research Could Lead to a Rare Disease Treatment for Many—Including His Daughter

    One year after Fran Sverdrup came to Saint Louis University to do medical research, his daughter was found to have a rare disease that had no treatment. Go find one, his boss urged.

    Read More
  • Antegrin

    Antegrin Expands Portfolio with Orally Available Integrin Antagonists

    The licensing of these compounds is an important step towards Antegrin’s commercialization of effective integrin-targeting therapies.

    Read More
  • Img 2640

    Ultragenyx Funds Researcher’s Quest to Treat His Daughter’s Disease

    Contract Will Accelerate Muscular Dystrophy Research

    Read More
  • 40%

    of worldwide deaths are caused by organ fibrosis

  • 800,000

    deaths annually are due to cryptococcus neoformans

  • 1 in 7,500

    births result in Facioscapulohumeral Muscular Dystrophy